Drug Database
Back to search

Poland· PL-100402385

Hydrochlorothiazide Aurovitas

A hydrochlorothiazide product containing hydrochlorothiazidum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC C03AA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHydrochlorothiazide AurovitasATCC03AA03REGISTER NO.PL-100402385PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydrochlorothiazidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydrochlorothiazide is registered in 16 of 19 countries.

Countries holding a registration under ATC C03AA03 (hydrochlorothiazide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search hydrochlorothiazide products by name

Hydrochlorothiazide · ATC C03AA03

16 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of hydrochlorothiazide costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.048 in France to $0.21 in Switzerland — a ×4.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Hydrochlorothiazide · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.21
  • IT Italy$0.075
  • FR France$0.048
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Hydrochlorothiazidum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C03AA03
ATC class
Hydrochlorothiazide
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 8

  • gtin
    05909991445294
  • gtin
    05909991445300
  • gtin
    05909991445317
  • gtin
    05909991445324
  • gtin
    05909991445331
  • gtin
    05909991445348
  • gtin
    05909991445355
  • gtin
    05909991559052

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for hydrochlorothiazide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydrochlorothiazide against other medicinesHow interaction checks work

Hydrochlorothiazide · interactions on record

490 records

  • 4 severe
  • 208 moderate
  • 21 minor
  • 169 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Aminolevulinic acidL01XD04severe
  • Arsenic trioxideL01XX27severe

88 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydrochlorothiazide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydrochlorothiazide products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Hct G.L.
  • Bulgaria · Hypodehydra, Дехидразид
  • Cyprus · Didralin, Hydrochlorothiazide Remedica
  • Czechia · Hydrochlorothiazid Léčiva
  • Germany · Hct 089pharm, Hct 1 A Pharma
  • Denmark · Hydrochlorothiazide Orifarm, Hydromed
  • Estonia · Hypothiazid
  • Spain · Drine, Esidrex
  • Finland · Hydrex, Hydrex Semi
  • France · Esidrex, Hydrochlorothiazide Arrow
  • United Kingdom (Northern Ireland) · Hydrochlorothiazide Aspire Pharma
  • Greece · Diuren, Losazide
  • Hungary · Hypothiazid
  • Iceland · Hydromed
  • Italy · Esidrex, Idroclorotiazide Aurobindo
  • Lithuania · Hypothiazid
  • Latvia · Hypothiazid
  • Netherlands · Hydrochloorthiazide 1a Pharma, Hydrochloorthiazide Aurobindo
  • Norway · Esidrex, Hydrochlorothiazide Orifarm
  • Portugal · Hidroclorotiazida Bluefish, Hidroclorotiazida Generis
  • Romania · Nefrix
  • Sweden · Esidrex, Hydrochlorothiazide Bluefish
  • Slovakia · Hydrochlorothiazid Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c765a0f8-e163-44e0-b91b-ef141eefd013
GET /v1/drugs/c765a0f8-e163-44e0-b91b-ef141eefd013?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "05909991445294 ¦ Rp ¦ 138769\n20 tabl.\n05909991445300 ¦ Rp ¦ 138770\n30 tabl.\n05909991445317 ¦ Rp ¦ 138771\n50 tabl.\n05909991445324 ¦ Rp ¦ 138772\n60 tabl.\n05909991445331 ¦ Rp ¦ 138773\n90 tabl.\n05909991445348 ¦ Rp ¦ 138774\n100 tabl.\n05909991445355 ¦ Rp ¦ 138775\n500 tabl.\n05909991559052 ¦ Rp ¦ 158957\n40 tabl.",
  "substance": "Hydrochlorothiazidum 25 mg",
  "common_name": "Hydrochlorothiazidum",
  "pl_product_id": "100402385",
  "pozwolenie_nr": "26194",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console